JoeB131
Diamond Member
It doesn't work anywhere else either....the only way the social welfare states can manage right now, as their costs sky rocket and the quality of care declines at an ever faster rate.....is the United States is protecting them with our military and Americans are funding almost all medical innovation and medicinal drug creation....without the U.S. to protect them, they would have to pay for their own militaries to actually work.......and without the U.S medical and drug innovation and creation, they would still be using leaches and draining blood from sick people........
let's unpack this bit of crazy as 2TinyGuy tries to put together an argument without the NRA telling him what to think.
The European Social Welfare states spend less per capital than we do, they have longer life expectencies, they have lower infant mortality rates and they have a higher satisfaction rate with their systems than we have with ours.
The reason they aren't spending money on their military is THEY DON'T NEED TO. We don't, either, really. We could slash the military spending in half and stop trying to police the world, and the world would probably be fine.
Oh, and quite the contrary, letting big insurance and big pharma rape us is not leading to medical innovation. In fact, the US is slipping in that regard.
U.S. Slipping as Global Leader in Medical Research
Medical research has become an increasingly global endeavor and investments by other countries, particularly in Asia, are eroding U.S. leadership. In 2004, U.S. medical R&D spending represented 57 percent of the global total. By 2014, the U.S. share had fallen to 44 percent with Asia – led by China, Japan, South Korea, India, and Singapore – rapidly making up ground and increasing investment by 9.4 percent per year. If current trends continue, the U.S. will be overtaken by China as the global leader in medical R&D in the next ten years. China has already surpassed the U.S. in terms of the size of its science and technology workforce and global share of patents for medical technologies, and is closing the gap in published biomedical research articles.